Edition:
United Kingdom

Array Biopharma Inc (ARRY.OQ)

ARRY.OQ on NASDAQ Stock Exchange Global Market

15.15USD
19 Oct 2018
Change (% chg)

$-0.31 (-2.01%)
Prev Close
$15.46
Open
$15.49
Day's High
$15.65
Day's Low
$15.02
Volume
670,909
Avg. Vol
690,466
52-wk High
$20.20
52-wk Low
$10.03

Select another date:

Wed, Jun 27 2018

Photo

Array BioPharma gets FDA nod for melanoma combo treatment

The U.S. Food and Drug Administration said on Wednesday it approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.

UPDATE 2-Array BioPharma gets FDA nod for melanoma combo treatment

June 27 The U.S. Food and Drug Administration said on Wednesday it approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.

CORRECTED-UPDATE 1-FDA approves Array BioPharma's melanoma combo treatment

June 27 The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.

CORRECTED-Array's melanoma combo treatment wins FDA approval

June 27 The U.S. Food and Drug Administration said on Wednesday it had approved Array BioPharma Inc's combination treatment for use in patients with the deadliest form of skin cancer.

BRIEF-Array Biopharma Says Entered Into Controlled Equity Offerings Sales Agreement With Cantor Fitzgerald

* ARRAY BIOPHARMA INC SAYS ENTERED INTO CONTROLLED EQUITY OFFERINGSM SALES AGREEMENT WITH CANTOR FITZGERALD & CO - SEC FILING

BRIEF-Array Biopharma Reports Q3 Loss Per Share $0.11

* ARRAY BIOPHARMA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF FISCAL 2018

Select another date: